Statistical Considerations for the Design of the Optimal Clinical Trial
Authors:
- G. S. DoigGDG. S. Doig
- J. RochonJRJ. Rochon
- 1 January 1995
- book chapter
- Published by Springer Nature
- p. 345-353
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis1993
- A Multicenter Trial for Resuscitation of Injured Patients With 7.5% Sodium ChlorideArchives of Surgery, 1993
- General Guidelines for the Clinical Evaluation of Anti-Infective Drug ProductsClinical Infectious Diseases, 1992
- Statistical Problems in the Design of Antiarrhythmic Drug TrialsJournal of Cardiovascular Pharmacology, 1992
- 7.5% Sodium Chloride/Dextran for Resuscitation of Trauma Patients Undergoing Helicopter TransportArchives of Surgery, 1991
- A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized TrialThe Journal of Infectious Diseases, 1988
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Single-center versus multicenter trials1986